Effect of anti-TNF therapy and vitamin D derivatives on the proliferation of peripheral blood mononuclear cells in Crohn's disease.
Infliximab treatment demonstrated clinical and endoscopic benefits in active refractory and fistulizing Crohn's disease. The aim of this research was to investigate the proliferative response of peripheral blood mononuclear cells (PBMC) obtained from patients with active and fistulizing Crohn's disease treated with infliximab therapy. PBMC proliferation and VDR protein levels were also studied when 1,25(OH)2D3 or its analogues (EB 1089, KH 1060) were added to cells cultures. At day 5 of culture, the proliferation of PBMC obtained from patients responsive to the therapy showed a remarkable decrease (about 60%) at T6 (after two infusions) with respect to T0 (before the first infusion). On the contrary, in the unresponsive patient, the proliferative response was four times higher at T6 in comparison with T0. Vitamin D derivatives induced a decrease in cell proliferation higher in responsive patients than in the unresponsive one. Increased VDR levels during therapy were registered only in the unresponsive patient. Our results indicate that PBMC proliferation and VDR expression may be useful indicators to predict the response of patients with Crohn's disease to the infliximab therapy.
Stio
Maria
M
Department of Biochemical Sciences, University of Florence, Viale Morgagni 50, Florence, Italy. maria.stio@unifi.it
Treves
Cristina
C
Martinesi
Maria
M
d'Albasio
Giuseppe
G
Bagnoli
Siro
S
Bonanomi
Andrea G
AG
D000328:Adult; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003424:Crohn Disease / Q000097:blood*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000473:pathology*; D018167:Receptors, Calcitriol / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*; D014807:Vitamin D / Q000031:analogs & derivatives*
D000911:Antibodies, Monoclonal; D018167:Receptors, Calcitriol; D014409:Tumor Necrosis Factor-alpha; D014807:Vitamin D; D000069285:Infliximab